1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter's Fiver Forces Analysis 37
3 Segmentation of Europe Market by Vaccine Type 41
3.1 Market Overview by Vaccine Type 41
3.2 Live/Attenuated Vaccines 43
3.3 Inactivated Vaccines 44
3.4 Subunit Vaccines 45
3.5 Toxoid Vaccines 46
3.6 Conjugate Vaccines 47
3.7 Recombinant Vector Vaccines 48
3.8 Other Vaccines 49
4 Segmentation of Europe Market by Disease 50
4.1 Market Overview by Disease 50
4.2 Vaccines for Pneumococcal Disease 52
4.3 Vaccines for Poliovirus 53
4.4 Vaccines for Hepatitis 54
4.5 Vaccines for Influenza 55
4.6 Vaccines for Measles, Mumps, and Rubella (MMR) 56
4.7 Vaccines for Varicella 57
4.8 Vaccines for Human Papilloma Virus 58
4.9 Vaccines for COVID-19 59
4.10 Vaccines for Other Diseases 60
5 Segmentation of Europe Market by Administration 61
5.1 Market Overview by Administration 61
5.2 Intramuscular Route 63
5.3 Subcutaneous Route 64
5.4 Oral Route 65
5.5 Intravenous Injection 66
5.6 Other Administration Routes 67
6 Segmentation of Europe Market by Patient 68
6.1 Market Overview by Patient 68
6.2 Pediatric Vaccines 70
6.3 Adult Vaccines 72
7 European Market 2019-2026 by Country 74
7.1 Overview of European Market 74
7.2 UK 77
7.3 France 80
7.4 Germany 83
7.5 Spain 86
7.6 Italy 89
7.7 Russia 92
7.8 Rest of European Market 95
8 Competitive Landscape 97
8.1 Overview of Key Vendors 97
8.2 New Product Launch, Partnership, Investment, and M&A 100
8.3 Company Profiles 101
AstraZeneca plc 101
Bavarian Nordic A/S 103
China National Biotec Group Company Ltd. 104
CSL Ltd. 105
Daiichi Sankyo Co. Ltd 106
Emergent BioSolutions Inc. 107
GlaxoSmithKline PLC 108
Johnson & Johnson 109
Merck & Co. 110
Novavax, Inc. 111
Pfizer Inc. 112
Sanofi SA 113
Takeda Pharmaceutical Co. Ltd 114
9 Investing in Europe Market: Risk Assessment and Management 115
9.1 Risk Evaluation of Europe Market 115
9.2 Critical Success Factors (CSFs) 118
Related Reports and Products 121